YBX1 and nasopharyngeal carcinoma: MiR-379-5p inhibits the epithelial-mesenchymal transition (EMT) of nasopharyngeal carcinoma cells and the PI3K/Akt pathway in osteoarthritis chondrocytes by targeting YBX1 (49, 50).